MedTrace Logo

Immune Modulators and IVF

NCT02626702 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-09-16

No results posted yet for this study

Summary

Exploring the immune mediators of early pregnancy prospectively may help to identify new early interventions that will increase the likelihood of success and help women make informed decisions regarding their pregnancies.

Conditions

  • In Vitro Fertilization

Interventions

OTHER

Observational

Excess blood from subjects will be analyzed to explore the relationship between Immune Modulators and IVF outcomes.

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Steven Spandorfer, MD · Weill Medical College of Cornell University

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2019-08-09
Completion
2019-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02626702 on ClinicalTrials.gov